Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

N. Nathalie Bouwer; T. G. Steenbruggen; H. N. Rier; J. J. E. M. Kitzen; K. J. Beelen; A. J. Ten Tije; P. C. De Jong; J. C. Drooger; C. Holterhues; J. Van Rosmalen; M. J. M. Kofflard; E. Boersma; G. S. Sonke; M-D Levin; A. Jager

doi:10.1002/ejhf.1488

Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

N. Nathalie Bouwer, T. G. Steenbruggen, H. N. Rier, J. J. E. M. Kitzen, K. J. Beelen, A. J. Ten Tije, P. C. De Jong, J. C. Drooger, C. Holterhues, J. Van Rosmalen, M. J. M. Kofflard, E. Boersma, G. S. Sonke, M-D Levin, A. Jager

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

6 Citations (Scopus)

98 Downloads (Pure)

Original language	English
Article number	P1170
Pages (from-to)	289-290
Number of pages	2
Journal	European Journal of Heart Failure
Volume	21
Issue number	Suppl 1
DOIs	https://doi.org/10.1002/ejhf.1488
Publication status	Published - 26 May 2019

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ejhf.1488

European J of Heart Fail - 2019 - - Abstracts ProgrammeFinal published version, 61 MB

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.1488

Cite this

Bouwer, N. N., Steenbruggen, T. G., Rier, H. N., Kitzen, J. J. E. M., Beelen, K. J., Ten Tije, A. J., De Jong, P. C., Drooger, J. C., Holterhues, C., Van Rosmalen, J., Kofflard, M. J. M., Boersma, E., Sonke, G. S., Levin, M.-D., & Jager, A. (2019). Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors. European Journal of Heart Failure, 21(Suppl 1), 289-290. Article P1170. https://doi.org/10.1002/ejhf.1488

@article{6a02f31f54f1446d9b098928dd33849c,

title = "Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.",

author = "Bouwer, {N. Nathalie} and Steenbruggen, {T. G.} and Rier, {H. N.} and Kitzen, {J. J. E. M.} and Beelen, {K. J.} and {Ten Tije}, {A. J.} and {De Jong}, {P. C.} and Drooger, {J. C.} and C. Holterhues and {Van Rosmalen}, J. and Kofflard, {M. J. M.} and E. Boersma and Sonke, {G. S.} and M-D Levin and A. Jager",

note = "{\textcopyright} 2019 The Authors",

year = "2019",

month = may,

day = "26",

doi = "10.1002/ejhf.1488",

language = "English",

volume = "21",

pages = "289--290",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley & Sons Ltd.",

number = "Suppl 1",

}

Bouwer, NN, Steenbruggen, TG, Rier, HN, Kitzen, JJEM, Beelen, KJ, Ten Tije, AJ, De Jong, PC, Drooger, JC, Holterhues, C, Van Rosmalen, J, Kofflard, MJM, Boersma, E, Sonke, GS, Levin, M-D & Jager, A 2019, 'Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.', European Journal of Heart Failure, vol. 21, no. Suppl 1, P1170, pp. 289-290. https://doi.org/10.1002/ejhf.1488

Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors. / Bouwer, N. Nathalie; Steenbruggen, T. G.; Rier, H. N. et al.
In: European Journal of Heart Failure, Vol. 21, No. Suppl 1, P1170, 26.05.2019, p. 289-290.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

AU - Bouwer, N. Nathalie

AU - Steenbruggen, T. G.

AU - Rier, H. N.

AU - Kitzen, J. J. E. M.

AU - Beelen, K. J.

AU - Ten Tije, A. J.

AU - De Jong, P. C.

AU - Drooger, J. C.

AU - Holterhues, C.

AU - Van Rosmalen, J.

AU - Kofflard, M. J. M.

AU - Boersma, E.

AU - Sonke, G. S.

AU - Levin, M-D

AU - Jager, A.

PY - 2019/5/26

Y1 - 2019/5/26

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000468990703117&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1002/ejhf.1488

DO - 10.1002/ejhf.1488

M3 - Meeting Abstract

C2 - 32745277

SN - 1388-9842

VL - 21

SP - 289

EP - 290

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - Suppl 1

M1 - P1170

ER -

Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this